Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,338Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Gowlings

02 3Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

Gowlings

Canada
arrow
2024 ACI Convention
Not Confirmed

Rivastigmine

Brand Name : EXELON PATCH 5

Patent Number : 2315784

Filing Date : 1999-01-08

Strength per Unit : 9.0mg / 5cm

Dosage Form : Patch

Human Or VET : Human

Route of Administration : Transdermal

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

blank

02

arrow
2024 ACI Convention
Not Confirmed

Gowlings

Canada
arrow
2024 ACI Convention
Not Confirmed

Rivastigmine

Brand Name : EXELON PATCH 10

Patent Number : 2315784

Filing Date : 1999-01-08

Strength per Unit : 18.0mg / 10cm

Dosage Form : Patch

Human Or VET : Human

Route of Administration : Transdermal

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

blank

03

arrow
2024 ACI Convention
Not Confirmed

Gowlings

Canada
arrow
2024 ACI Convention
Not Confirmed

Rivastigmine

Brand Name : EXELON PATCH 15

Patent Number : 2315784

Filing Date : 1999-01-08

Strength per Unit : 27.0 mg / 15 cm

Dosage Form : PATCH

Human Or VET : Human

Route of Administration : TRANSDERMAL

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

blank

04

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Rivastigmine

Brand Name :

Patent Number : 1284501

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2008-05-28

Date Granted :

blank

05

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Rivastigmine

Brand Name :

Patent Number : 1302853

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2009-09-01

Date Granted :

blank

06

arrow
2024 ACI Convention
Not Confirmed

Country
arrow
2024 ACI Convention
Not Confirmed

Rivastigmine

Brand Name :

Patent Number : 1307003

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2009-09-01

Date Granted :

blank